[go: up one dir, main page]

EP1427850A4 - Genes et jeux ordonnes d'echantillons humains pertinents sur le plan toxicologique - Google Patents

Genes et jeux ordonnes d'echantillons humains pertinents sur le plan toxicologique

Info

Publication number
EP1427850A4
EP1427850A4 EP02757259A EP02757259A EP1427850A4 EP 1427850 A4 EP1427850 A4 EP 1427850A4 EP 02757259 A EP02757259 A EP 02757259A EP 02757259 A EP02757259 A EP 02757259A EP 1427850 A4 EP1427850 A4 EP 1427850A4
Authority
EP
European Patent Office
Prior art keywords
arrays
human
relevant genes
toxicologically relevant
toxicologically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP02757259A
Other languages
German (de)
English (en)
Other versions
EP1427850A2 (fr
Inventor
Robin E Neft
Robert T Ii Dunn
Karissa Adkins
Gavin G Pickett
Larry D Kier
Katja Schmeiser
Phillippe Alen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Phase-1 Molecular Toxicology Inc
Original Assignee
Phase-1 Molecular Toxicology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Phase-1 Molecular Toxicology Inc filed Critical Phase-1 Molecular Toxicology Inc
Publication of EP1427850A2 publication Critical patent/EP1427850A2/fr
Publication of EP1427850A4 publication Critical patent/EP1427850A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP02757259A 2001-08-16 2002-08-16 Genes et jeux ordonnes d'echantillons humains pertinents sur le plan toxicologique Withdrawn EP1427850A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31308001P 2001-08-16 2001-08-16
US313080P 2001-08-16
PCT/US2002/026514 WO2003016500A2 (fr) 2001-08-16 2002-08-16 Genes et jeux ordonnes d'echantillons humains pertinents sur le plan toxicologique

Publications (2)

Publication Number Publication Date
EP1427850A2 EP1427850A2 (fr) 2004-06-16
EP1427850A4 true EP1427850A4 (fr) 2006-02-08

Family

ID=23214292

Family Applications (1)

Application Number Title Priority Date Filing Date
EP02757259A Withdrawn EP1427850A4 (fr) 2001-08-16 2002-08-16 Genes et jeux ordonnes d'echantillons humains pertinents sur le plan toxicologique

Country Status (3)

Country Link
EP (1) EP1427850A4 (fr)
AU (1) AU2002323286A1 (fr)
WO (1) WO2003016500A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050283854A1 (en) 2003-05-23 2005-12-22 Anton Krumm Recombinant vectors for use in position-independent transgene expression within chromatin
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
EP1827507A4 (fr) * 2004-11-30 2008-06-25 Bg Medicine Inc Analyse systemique biologique
FR2890080B1 (fr) * 2005-08-30 2012-12-14 Vigilent Technologies Procede in vitro pour tester la toxicite d'un compose et dispositif pour sa mise en oeuvre
CA2661647C (fr) * 2006-08-24 2013-02-05 Hiroshima University Procede d'amplification poussee d'un gene cible dans une cellule de mammifere et vecteur correspondant
US9089588B2 (en) * 2010-05-03 2015-07-28 Curna, Inc. Treatment of sirtuin (SIRT) related diseases by inhibition of natural antisense transcript to a sirtuin (SIRT)
KR102165245B1 (ko) * 2013-05-21 2020-10-13 한양대학교 에리카산학협력단 유해 화학물질에 대한 노출 가능성 판단방법
GB2566516A (en) 2017-09-15 2019-03-20 Univ Oxford Innovation Ltd Electrochemical recognition and quantification of cytochrome c oxidase expression in bacteria
CN116209776A (zh) * 2020-05-29 2023-06-02 宾夕法尼亚大学董事会 用于检测包括冠状病毒在内的呼吸道病毒的组合物和方法
CN115452813B (zh) * 2022-09-02 2025-06-06 天方药业有限公司 一种含有喹啉环结构的药物细菌内毒素的检测方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811231A (en) * 1993-01-21 1998-09-22 Pres. And Fellows Of Harvard College Methods and kits for eukaryotic gene profiling
WO2001011030A2 (fr) * 1999-08-10 2001-02-15 Develogen Ag Für Entwicklungsbiologische Forschung Procede et moyen permettant d'induire la multiplication cellulaire de cellules au repos
WO2001032928A2 (fr) * 1999-11-05 2001-05-10 Phase-1 Molecular Toxicology Methodes permettant de determiner une hypersensibilite a un agent
WO2003062395A2 (fr) * 2002-01-18 2003-07-31 Bristol-Myers Squibb Company Identification de polynucleotides et de polypeptides permettant de prevoir l'activite de composes qui interagissent avec des proteine tyrosine kinases et/ou des voies de proteine tyrosine kinases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6160105A (en) * 1998-10-13 2000-12-12 Incyte Pharmaceuticals, Inc. Monitoring toxicological responses
US20020192671A1 (en) * 2001-01-23 2002-12-19 Castle Arthur L. Method and system for predicting the biological activity, including toxicology and toxicity, of substances

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811231A (en) * 1993-01-21 1998-09-22 Pres. And Fellows Of Harvard College Methods and kits for eukaryotic gene profiling
WO2001011030A2 (fr) * 1999-08-10 2001-02-15 Develogen Ag Für Entwicklungsbiologische Forschung Procede et moyen permettant d'induire la multiplication cellulaire de cellules au repos
WO2001032928A2 (fr) * 1999-11-05 2001-05-10 Phase-1 Molecular Toxicology Methodes permettant de determiner une hypersensibilite a un agent
WO2003062395A2 (fr) * 2002-01-18 2003-07-31 Bristol-Myers Squibb Company Identification de polynucleotides et de polypeptides permettant de prevoir l'activite de composes qui interagissent avec des proteine tyrosine kinases et/ou des voies de proteine tyrosine kinases

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
YU ZHE ET AL: "Identification of genes responsive to BPDE treatment in HeLa cells using cDNA expression assays", ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, vol. 36, no. 3, 2000, pages 201 - 205, XP009054561, ISSN: 0893-6692 *

Also Published As

Publication number Publication date
EP1427850A2 (fr) 2004-06-16
WO2003016500A3 (fr) 2003-06-19
AU2002323286A1 (en) 2003-03-03
WO2003016500A2 (fr) 2003-02-27

Similar Documents

Publication Publication Date Title
IL161976A0 (en) Cell and tissue arrays and microarrays and methodsof use
AU2002303261A8 (en) Gene brcc2 and diagnostic and therapeutic uses thereof
AU2002258728A1 (en) Gene brcc-3 and diagnostic and therapeutic uses thereof
AU2002305151A1 (en) Gene scc-112 and diagnostic and therapeutic uses thereof
AU2002252976A1 (en) Hydrazones and their therapeutic use
EP1427850A4 (fr) Genes et jeux ordonnes d'echantillons humains pertinents sur le plan toxicologique
GB0119025D0 (en) Compounds and their therapeutic use
GB0127657D0 (en) Virulence genes and proteins and their use
GB0115780D0 (en) Therapeutic molecules and uses thereof
AU2002303262A1 (en) Gene shinc-1 and diagnostic and therapeutic uses thereof
GB0321694D0 (en) Genes and their therapeutic use
GB0207409D0 (en) Benzofuran-2H-3-one compounds and their therapeutic use
GB2376943B (en) Compounds and their therapeutic use
GB0112237D0 (en) Compounds and their therapeutic use
GB0105922D0 (en) Genes and proteins, and their use
GB0128122D0 (en) Therapeutic use
GB0123991D0 (en) New therapeutic use
GB0215773D0 (en) Compunds and their therapeutic use
SE0100096D0 (sv) Tissue specific genes and their promotors - apoptosis
GB0106063D0 (en) Libraries and their use
EP1284288A4 (fr) Genes associes a l'apoptose humaine et proteines produites associees a l'apoptose humaine
AU2002321141A1 (en) Pyrimidinoxyalkylpiperazines and their therapeutic use
GB0201615D0 (en) Compounds and their therapeutic use
GB0128512D0 (en) Compounds and their therapeutic use
GB0123170D0 (en) Genes,proteins,and their use

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040316

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20051228

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060301